Theresa Heggie sold $505K of BioCryst Pharmaceuticals (BCRX)

Executed Mar 20, disclosed Mar 24, 4 days later.

Value, as filed

$505K

49,933 sh × $10.11

Executed

Mar 20

the trade date, as filed

Disclosed

Mar 24

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TH Theresa Heggie Director profile →

Theresa Heggie (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in BioCryst Pharmaceuticals, Inc. (BCRX). The largest single filing was $505K of BCRX (49,933 sh × $10.11, as filed), executed Mar 20.

The name

BCRX BioCryst Pharmaceuticals, Inc. BCRX · Healthcare · 10 filings in 24 months ticker →

Healthcare · BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Theresa Heggie in BCRX

BCRXSALE BioCryst Pharmaceuticals, Inc. $596K
70,000 sh × $8.51
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET